Stockscreener 앱 받기
1.445
3.60%
0.055
전일 마감가:
$1.39
열려 있는:
$1.4
하루 거래량:
763.20K
Relative Volume:
0.04
시가총액:
$140.96M
수익:
$1.20M
순이익/손실:
$-52.41M
주가수익비율:
-1.5879
EPS:
-0.91
순현금흐름:
$-31.25M
1주 성능:
+6.67%
1개월 성능:
-7.69%
6개월 성능:
+139.44%
1년 성능:
+5.88%
1일 변동 폭
$1.37
$1.458
1주일 범위
$1.285
$1.458
52주 변동 폭
$0.387
$3.87
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
명칭
Rani Therapeutics Holdings Inc
전화
(408) 457-3700
주소
2051 RINGWOOD AVENUE, SAN JOSE
RANI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RANI
Rani Therapeutics Holdings Inc
|
1.445 | 135.60M | 1.20M | -52.41M | -31.25M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
482.03 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
815.08 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
415.22 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
812.24 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
171.16 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-02 | 개시 | Oppenheimer | Outperform |
| 2024-06-14 | 개시 | Maxim Group | Buy |
| 2024-06-13 | 개시 | Rodman & Renshaw | Buy |
| 2023-04-17 | 재개 | BTIG Research | Buy |
| 2022-10-11 | 개시 | UBS | Buy |
| 2022-07-27 | 개시 | H.C. Wainwright | Buy |
| 2022-06-13 | 개시 | Wedbush | Outperform |
모두보기
Rani Therapeutics Holdings Inc 주식(RANI)의 최신 뉴스
Rani Therapeutics begins phase 1 trial of oral obesity treatment By Investing.com - Investing.com Australia
Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen - The Manila Times
Rani Therapeutics Initiates Phase 1 Study of RT-114 - GlobeNewswire
Rani Therapeutics finalizes governance and capital structure changes - MSN
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Rani Therapeutics amends charter, reduces Class B voting power and ends tax agreement - Investing.com Nigeria
Rani Therapeutics (NASDAQ:RANI) Stock Price Down 2.2%What's Next? - MarketBeat
Analyst Upgrade: Will Rani Therapeutics Holdings Inc. stock outperform tech sector in 2025Quarterly Market Summary & Proven Capital Preservation Tips - moha.gov.vn
Verrica Pharmaceuticals (VRCA) Stock Price, Quote, News & History - Benzinga
Rani Therapeutics Holdings, Inc.(NasdaqGM: RANI) added to NASDAQ Biotechnology Index - marketscreener.com
Will Rani Therapeutics Holdings Inc. stock outperform tech sector in 2025Market Activity Recap & AI Based Buy/Sell Signal Reports - Улправда
Can Rani Therapeutics Holdings Inc. stock beat market expectations this quarterForecast Cut & Short-Term High Return Ideas - Улправда
Buy Signal: Will Rani Therapeutics Holdings Inc. stock outperform tech sector in 2025Weekly Stock Summary & Real-Time Market Sentiment Reports - Улправда
Can Rani Therapeutics Holdings Inc. stock hit record highs againMarket Risk Analysis & Daily Risk Controlled Trade Plans - DonanımHaber
How Rani Therapeutics Holdings Inc. stock compares to growth peersWeekly Gains Report & Expert-Curated Trade Recommendations - DonanımHaber
Is Rani Therapeutics Holdings Inc. stock attractive after correctionJuly 2025 Sentiment & Stock Portfolio Risk Control - DonanımHaber
What Wall Street predicts for Rani Therapeutics Holdings Inc. stock price2025 Fundamental Recap & Reliable Breakout Forecasts - DonanımHaber
Can Rani Therapeutics Holdings Inc. stock rebound after recent weaknessMarket Activity Summary & Fast Gaining Stock Strategy Reports - Улправда
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Rani Therapeutics (NASDAQ:RANI) Stock Price Up 1.3%Here's Why - MarketBeat
Rani Therapeutics (RANI) outlines $60.3M financing, 125M-share warrants and new governance terms - Stock Titan
RANI Stock Today, 28 November 2025: Price Action, Options Expiry and Outlook After the $1 Billion Chugai Deal - ts2.tech
Block Trades: Can Rani Therapeutics Holdings Inc. stock beat market expectations this quarterTrade Signal Summary & Weekly Momentum Picks - BỘ NỘI VỤ
Rani Therapeutics to Participate in the Evercore Healthcare Conference - The Manila Times
Why Is Rani Therapeutics’ Stock Skyrocketing Pre-Market Today? - MSN
What drives Rani Therapeutics Holdings Inc stock pricePrice-to-Earnings Ratio Insights & Minimal Investment Portfolio Growth - earlytimes.in
Will Rani Therapeutics Holdings Inc. stock gain from government policiesMarket Movement Recap & Consistent Profit Trading Strategies - newser.com
Technical analysis overview for Rani Therapeutics Holdings Inc. stockJuly 2025 Selloffs & Reliable Trade Execution Plans - newser.com
Is Rani Therapeutics Holdings Inc. stock trading at a premium valuationEarnings Overview Report & Low Drawdown Trading Techniques - newser.com
RANI Stock Today (Nov 19, 2025): Rani Therapeutics slips to $1.75 as traders weigh October’s Chugai deal and year‑end catalysts - ts2.tech
How Rani Therapeutics Holdings Inc. stock compares to market leadersQuarterly Portfolio Review & Consistent Growth Equity Picks - newser.com
Institutional scanner results for Rani Therapeutics Holdings Inc.Earnings Summary Report & Daily Momentum Trading Reports - newser.com
How high can Rani Therapeutics Holdings Inc. stock goLong Setup & Consistent Income Trade Ideas - newser.com
Short interest data insights for Rani Therapeutics Holdings Inc.July 2025 Market Mood & Weekly Momentum Picks - newser.com
How Rani Therapeutics Holdings Inc. stock benefits from global expansionVolume Spike & Weekly Watchlist for Hot Stocks - newser.com
Vasudev Jaiprakash Bailey Net Worth (2025) - GuruFocus
Will Rani Therapeutics Holdings Inc. bounce back from current supportStock Surge & AI Forecasted Entry/Exit Points - newser.com
How to integrate Rani Therapeutics Holdings Inc. into portfolio analysis toolsJuly 2025 Drop Watch & Low Drawdown Investment Strategies - newser.com
Rani Therapeutics Holdings (RANI) Price Target Decreased by 11.90% to 9.44 - MSN
Is Rani Therapeutics Holdings Inc. stock a buy for dividend growthJuly 2025 Retail & Advanced Technical Signal Analysis - newser.com
Is Rani Therapeutics Holdings Inc. stock supported by innovation pipeline2025 Key Lessons & Breakout Confirmation Alerts - newser.com
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Rani Therapeutics Holdings Inc (RANI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Rani Therapeutics Holdings Inc 주식 (RANI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| South Cone Investments Limited | 10% Owner |
Oct 21 '25 |
Sale |
2.77 |
4,000,000 |
11,074,000 |
2,379,194 |
| South Cone Investments Limited | 10% Owner |
Oct 20 '25 |
Sale |
2.41 |
1,923,000 |
4,637,314 |
6,379,194 |
6.23%
자본화:
|
볼륨(24시간):